Four Seasons Rehabilitation & Care in Durant, OK

Four Seasons Rehabilitation & Care is a medicare and medicaid certified nursing home in Durant, Oklahoma. It is located in Bryan county at 1212 Four Seasons Drive, Durant, Oklahoma 74701. You can reach out to the office of Four Seasons Rehabilitation & Care via phone at (580) 677-9911. This skilled nursing facility has 122 federally certified beds with average occupancy rate of 39.84%. Its legal business name is Scg Durant Four Seasons Llc and has the following ownership type - For Profit - Corporation.

Four Seasons Rehabilitation & Care (Medicare CCN 375238) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1995 (29 years certified) and the last quality survey was conducted in April, 2019.

Name	Four Seasons Rehabilitation & Care
Location	1212 Four Seasons Drive, Durant, Oklahoma
Certified By	Medicare and Medicaid
No. of Certified Beds	122
Occupancy Rate	39.84%
Medicare ID (CCN)	375238
Legal Business Name	Scg Durant Four Seasons Llc
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Four Seasons Rehabilitation & Care from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1215926928
Organization Name	SCG DURANT FOUR SEASONS LLC
Doing Business As	FOUR SEASONS NURSING CENTER OF DURANT
Address	1212 Four Seasons Dr, Durant, OK 74701
Phone Number	580-924-5300

News Archive

Global Fund taps former HHS Sec., former President of Botswana to lead external investigation of its financial controls

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday named former HHS Secretary Michael Leavitt and former President of Botswana Festus Mogae to co-chair "an external review of its financial systems, amid heightened scrutiny from donors over misuse of some grants and a potential funding reduction from the U.S.," the Wall Street Journal reports.

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

Male patients with lupus often have more severe disease, receive little support

A national survey of male patients with lupus finds the illness has a significant impact on their physical and emotional health, yet they often do not receive support that could help them cope.

Novel tetracyclines with improved potency, efficacy against contemporary P. aeruginosa isolates

Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results from studies that demonstrate the improved potency and pharmacokinetics of several of its newest discovery-stage tetracycline analogs.

Study finds no genetic evidence to prove vitamin D protects against coronavirus

While previous research early in the pandemic suggested that the vitamin D cuts the risk of contracting COVID-19, a new study from McGill University finds there is no genetic evidence that the vitamin works as a protective measure against the coronavirus.

Read more Medical News

› Verified 9 days ago

NPI Number	1275106163
Organization Name	DURANT FOUR SEASONS OPERATING CO., LLC
Address	1212 Four Seasons Dr, Durant, OK 74701
Phone Number	580-677-9911

News Archive

Global Fund taps former HHS Sec., former President of Botswana to lead external investigation of its financial controls

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday named former HHS Secretary Michael Leavitt and former President of Botswana Festus Mogae to co-chair "an external review of its financial systems, amid heightened scrutiny from donors over misuse of some grants and a potential funding reduction from the U.S.," the Wall Street Journal reports.

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

Male patients with lupus often have more severe disease, receive little support

A national survey of male patients with lupus finds the illness has a significant impact on their physical and emotional health, yet they often do not receive support that could help them cope.

Novel tetracyclines with improved potency, efficacy against contemporary P. aeruginosa isolates

Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results from studies that demonstrate the improved potency and pharmacokinetics of several of its newest discovery-stage tetracycline analogs.

Study finds no genetic evidence to prove vitamin D protects against coronavirus

While previous research early in the pandemic suggested that the vitamin D cuts the risk of contracting COVID-19, a new study from McGill University finds there is no genetic evidence that the vitamin works as a protective measure against the coronavirus.

Read more Medical News

› Verified 9 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Four Seasons Rehabilitation & Care are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Four Seasons Rehabilitation & Care give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Global Fund taps former HHS Sec., former President of Botswana to lead external investigation of its financial controls

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday named former HHS Secretary Michael Leavitt and former President of Botswana Festus Mogae to co-chair "an external review of its financial systems, amid heightened scrutiny from donors over misuse of some grants and a potential funding reduction from the U.S.," the Wall Street Journal reports.

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

Male patients with lupus often have more severe disease, receive little support

A national survey of male patients with lupus finds the illness has a significant impact on their physical and emotional health, yet they often do not receive support that could help them cope.

Novel tetracyclines with improved potency, efficacy against contemporary P. aeruginosa isolates

Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results from studies that demonstrate the improved potency and pharmacokinetics of several of its newest discovery-stage tetracycline analogs.

Study finds no genetic evidence to prove vitamin D protects against coronavirus

While previous research early in the pandemic suggested that the vitamin D cuts the risk of contracting COVID-19, a new study from McGill University finds there is no genetic evidence that the vitamin works as a protective measure against the coronavirus.

Read more Medical News

› Verified 9 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	1
Total Amount of Fines in Dollars	$7500
Number of Payment Denials	1
Total Number of Penalties	2

The resident survey data of Four Seasons Rehabilitation & Care is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	8.95	14.46
Percentage of long-stay residents who lose too much weight	2.67	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	43.7	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	3.99	1.79
Percentage of long-stay residents with a urinary tract infection	5.26	2.65
Percentage of long-stay residents who have depressive symptoms	8.7	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	3.64	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	93.64	93.87
Percentage of long-stay residents who received an antipsychotic medication	23.35	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	87.32	83.88
Percentage of short-stay residents who newly received an antipsychotic medication	2.7	1.79
Percentage of long-stay residents whose ability to move independently worsened	12.87	17.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication	36.55	19.7
Percentage of high risk long-stay residents with pressure ulcers	20.83	7.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine	97.54	95.98